Department of Neurosurgery, Seoul National University Hospital, Seoul, Korea.
Department of Neurosurgery, Pusan National University Hospital, Busan, Korea.
J Korean Med Sci. 2024 Aug 19;39(32):e229. doi: 10.3346/jkms.2024.39.e229.
We aimed to evaluate long-term outcomes of gamma knife radiosurgery (GKS) for cerebral cavernous malformations (CCMs).
Among the 233 CCM patients who underwent GKS, 79 adult patients (96 lesions) followed for over 10 years were included and analyzed retrospectively. Annual hemorrhage rate (AHR) was analyzed the entire cohort of 233 patients and the subset of 79 enrolled patients by dividing lesions into overall CCM lesions and brainstem lesions. AHR, neurologic outcome, adverse radiation effect (ARE), and changes of lesions in magnetic resonance imaging (MRI) were compared before and after GKS. Cox-regression analysis was performed to identify risk factors for hemorrhage following GKS.
Mean follow-up duration of 79 enrolled patients was 14 years (range, 10-23 years). The AHR of all CCMs for entire cohort at each time point was 17.8% (pre-GKS), 5.9% (≤ 2 years post-GKS), 1.8% (≤ 10 years post-GKS). The AHR of all CCM for 79 enrolled patients was 21.4% (pre-GKS), 3.8% (2 years post-GKS), 1.4% (10 years post-GKS), and 2.3% (> 10 years post-GKS). The AHR of brainstem cavernous malformation (CM) for entire cohort at each time point was 22.4% (pre-GKS), 10.1% (≤ 2 years post-GKS), 3.2% (≤ 10 years post-GKS). The AHR of brainstem CM for 79 enrolled patients was 27.2% (pre-GKS), 5.8% (2 years post-GKS), 3.4% (10 years post-GKS), and 3.5% (> 10 years post-GKS). Out of the 79 enrolled patients, 35 presented with focal neurologic deficits at the initial clinical visit. Among these patients, 74.3% showed recovery at the last follow-up. Symptomatic ARE occurred in five (6.4%) patients. No mortality occurred. Most lesions were decreased in size at the last follow-up MRI. Previous hemorrhage history (hazard ratio [HR], 8.38; 95% confidence interval [CI], 1.07-65.88; = 0.043), and brainstem location (HR, 3.10; 95% CI, 1.26-7.64; = 0.014) were significant risk factors for hemorrhage event.
GKS for CCM showed favorable long-term outcomes. GKS should be considered for CCM, especially when it has a previous hemorrhage history and brainstem location.
我们旨在评估伽玛刀放射外科(GKS)治疗脑海绵状血管畸形(CCM)的长期疗效。
在 233 例接受 GKS 治疗的 CCM 患者中,回顾性纳入 79 例成年患者(96 个病灶),并对其进行了长达 10 年以上的随访。对整个 233 例患者队列和 79 例入组患者亚组,通过将病灶分为整体 CCM 病灶和脑干病灶,分析每年出血率(AHR)。比较 GKS 前后神经功能结局、放射性不良效应(ARE)、磁共振成像(MRI)中病灶变化。采用 Cox 回归分析识别 GKS 后出血的危险因素。
79 例入组患者的平均随访时间为 14 年(范围 10-23 年)。整个患者队列中,所有 CCM 病灶在各个时间点的 AHR 分别为 17.8%(GKS 前)、5.9%(GKS 后≤2 年)、1.8%(GKS 后≤10 年)。79 例入组患者中所有 CCM 的 AHR 分别为 21.4%(GKS 前)、3.8%(GKS 后 2 年)、1.4%(GKS 后 10 年)和 2.3%(GKS 后>10 年)。整个患者队列中脑干 CCM 的 AHR 在各个时间点分别为 22.4%(GKS 前)、10.1%(GKS 后≤2 年)、3.2%(GKS 后≤10 年)。79 例入组患者中脑干 CCM 的 AHR 分别为 27.2%(GKS 前)、5.8%(GKS 后 2 年)、3.4%(GKS 后 10 年)和 3.5%(GKS 后>10 年)。在 79 例入组患者中,35 例患者在初次就诊时存在局灶性神经功能缺损。在这些患者中,74.3%的患者在最后一次随访时得到了恢复。5 例(6.4%)患者出现症状性 ARE。无死亡病例发生。大多数病灶在最后一次 MRI 随访时缩小。既往出血史(危险比 [HR],8.38;95%置信区间 [CI],1.07-65.88; = 0.043)和脑干位置(HR,3.10;95% CI,1.26-7.64; = 0.014)是出血事件的显著危险因素。
GKS 治疗 CCM 具有良好的长期疗效。对于 CCM,尤其是有既往出血史和位于脑干的病灶,应考虑行 GKS 治疗。